US Approves H200 Chip Sales to Chinese Buyers, Jensen Huang in Beijing Amid Trade Talks
The U.S. government approved NVIDIA H200 sales to 10 Chinese companies as CEO Jensen Huang appeared in Beijing during Trump-Xi summit talks. This signals a thaw in AI chip export restrictions and underscores continued capex momentum despite trade tensions, lifting NVDA toward $6 trillion market cap and pressuring semiconductor narrowness.
RKey facts
- U.S. government approved NVIDIA H200 chip sales to 10 Chinese companies
- NVIDIA CEO Jensen Huang appeared in Beijing during Trump-Xi summit
- NVDA shares rallied 20% in seven days to near $6 trillion market cap
- Trump stated Xi likes idea of buying more U.S. oil
- CEOs including Musk, Huang, Cook attended state banquet at Great Hall of the People
What's happening
The narrative of US-China semiconductor decoupling hit a significant speed bump today as multiple sources confirmed that the US government approved NVIDIA H200 chip sales to Chinese buyers. Jensen Huang's presence in Beijing during the Trump-Xi summit, combined with official US approval for advanced chip exports, suggests that despite rhetoric around technology competition, both governments are finding pragmatic pathways for AI infrastructure buildout. This reversal stands in sharp contrast to earlier speculation that the administration would tighten export controls; instead, the trade talks appear to be unlocking bilateral opportunities in critical technologies.
The scale of approval matters. Sources indicate 10 Chinese companies received clearance, a material expansion from prior restrictions. The timing coincides with Trump stating that Xi "likes the idea of buying more US oil," alongside agricultural purchase commitments. Huang's appearance at the Beijing state banquet alongside Elon Musk and Tim Cook underscores Silicon Valley's integration into top-level diplomatic engagement. NVIDIA shares extended a 20% rally over seven days, reaching near $6 trillion in market value as traders price in both continued AI capex and de-escalation in US-China tech friction.
The broader implication is bifurcated. On one hand, chipmakers and AI infrastructure plays benefit from a lifting of export uncertainty and a signal that US companies will retain access to high-margin Chinese buyers. On the other hand, the approval risks reigniting debate about national security and semiconductor controls; some analysts view this as evidence that AI capex competition, not geopolitical posturing, is driving policy. For broader equities, the narrative reinforces the thesis that the AI buildout is global, not just US-centric, and that Magnificent Seven tech stocks will continue to face upside momentumThe empirical fact that winners keep winning over the medium term. as capex cycles lengthen and internationalize.
Skeptics note that approvals for 10 firms does not constitute a full reversal of export controls, and that any future Trump-Xi friction could reverse gains quickly. Markets are assuming detente will hold through the remainder of Q2 2026, but geopolitical risk premiums remain embedded.
What to watch next
- 01Trump-Xi Beijing summit outcomes on trade and tech: ongoing
- 02NVIDIA H200 export approval process for additional Chinese firms: TBD
- 03US-China semiconductor policy updates: next weeks
- Financial TimesBig Tech groups launch global borrowing spree to fund AI expansion
US tech giants including Alphabet and Amazon are tapping foreign debt market at an unprecedented rate
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Willis Towers Watson plc - WTW
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Willis Towers Watson plc ("Willis Towers Watson" or the "Company") (NASDAQ: WTW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
2h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Blaize Holdings, Inc. - BZAI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Blaize Holdings, Inc. ("Blaize" or the "Company") (NASDAQ: BZAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
2h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Corporation - MRBK
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Corporation ("Meridian" or the "Company") (NASDAQ: MRBK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
2h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of JetBlue Airways Corporation - JBLU
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of JetBlue Airways Corporation ("JetBlue" or the "Company") (NASDAQ: JBLU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
2h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Compass Therapeutics, Inc. ("Compass" or the "Company") (NASDAQ: CMPX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
2h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sportradar Group AG - SRAD
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sportradar Group AG ("Sportradar" or the "Company") (NASDAQ: SRAD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
2h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Grace Therapeutics, Inc. ("Grace" or the "Company") (NASDAQ: GRCE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
2h ago
Related coverage
- Nvidia Gains 20% in Seven Days as H200 China Deal Approved, NVDA near $6 trillionTech & AI··0 mentions
- US Approves NVIDIA H200 Chip Sales to 10 Chinese Firms; Geopolitical TailwindTech & AI··0 mentions
- AI Buildout Broadens Into Networking: Cisco Soars as Infrastructure Spend WidensTech & AI··0 mentions
- Trump, Xi Meet in Beijing: Oil Purchases, Agricultural Deals, and Tech-Sector Optimism Drive Risk-On RallyEquities US··0 mentions
More about $NVDA
- AI Rally Crushes Active Stock Pickers; Only 1 in 4 Beating Market as Mega-Cap Dominance Persists·Tech & AI
- NVDA Cleared for H200 Sales to China; Trump Admin Approves Restricted Chip Exports, Easing Supply Chain Risk·Tech & AI
- Nasdaq Breadth Deteriorates as AI Mega-Caps Dominate; S&P 500 Concentration Hits Record·Tech & AI
- US Government Approves NVIDIA H200 Chip Sales to 10 Chinese Firms·Tech & AI
- AI Mega-Caps Push SPY to Records; Stock Picker Frustration Mounts·Equities US
Tracking AI infrastructure capex — hyperscaler spend, data center buildouts, memory demand and the margin compression risk.